ABPI calls on new UK government to address inequalities in access to medicines

The Association of the British Pharmaceutical Industry (ABPI) has been quick to congratulate Keir Starmer and the Labour party on their victory in the UK general election.

Unsurprisingly so, given the need for the trade group to work closely with the new government around access to medicines, support for the life sciences and other pressing matters impacting pharma in the UK.

The ABPI has also sought to point the new government towards its Manifesto for Investment, Health, and Growth, which sets out a plan to drive better health and fairness to patients in the National Health Service (NHS), boost patient access to new medicines via clinical trials, bring more manufacturing jobs and value to the UK, and create more highly-skilled well-paid jobs in all parts of the country.